The DOI matches its Crossref record.
The Effectiveness of the Xanthine Oxidase Inhibitor Allopurinol in the Treatment of Gout
Abstract
THE CLINICAL BENEFITS DERIVED from con-trolling the hyperuricemia of patients with gouty arthritis have been well-estab-lished (1, 2). This has been achieved by using uricosuric drugs to increase the renal excretion of uric acid, thereby lowering the serum urate concentration. Since the ma-jority of patients with gout have evidence of some degree of overproduction of uric acid (3), another rational approach to ther-apy would be to decrease uric acid produc-tion. A decrease in purine biosynthesis in the human has been produced by the ad-ministration of the glutamine analogues 6-diazo-5 oxo-L-norleucine (DON) (4) and azaserine (5), which block an early stage of purine biosynthesis; however, toxic side effects precluded their clinical use. Inhi-Received October 15, 1964; accepted for publi-
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tumour lysis syndrome: new therapeutic strategies and classification
Cairo, M. S., & Bishop, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05094.x · Cited by 1,076
The purine path to chemotherapy
Elion, G. B. (1989) · Science · doi:10.1126/science.2649979 · Cited by 687
Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Gout
KELLEY, W. N., GREENE, M. L., ROSENBLOOM, F. M., HENDERSON, J. F., & SEEGMILLER, J. E. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-155 · Cited by 446
Self-citationPui, C.-H., Mahmoud, H. H., Wiley, J. M., Woods, G. M., Leverger, G., Camitta, B., Hastings, C., Blaney, S. M., Relling, M. V., & Reaman, G. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.697 · Cited by 361
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase
Elion, G. B., Kovensky, A., Hitchings, G. H., Metz, E., & Rundles, R. W. (1966) · Biochemical Pharmacology · doi:10.1016/0006-2952(66)90163-8 · Cited by 327
Metadata
- Authors
- KLINENBERG, J. R., GOLDFINGER, S. E., & SEEGMILLER, J. E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1965-04-01
- Volume
- 62
- Issue
- 4
- Pages
- 639-647
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2014990715
- Cited by
- 214
- References
- 0
- FWCI
- 19.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effectiveness of the Xanthine Oxidase Inhibitor Allopurinol in the Treatment of Gout. https://app.cochat.ai/papers/10.7326/0003-4819-62-4-639
- The paper
- KLINENBERG, J. R., GOLDFINGER, S. E., & SEEGMILLER, J. E. (1965). The Effectiveness of the Xanthine Oxidase Inhibitor Allopurinol in the Treatment of Gout. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-62-4-639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.